Clinical trial
A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a…
NCT00427661 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00427661 |
|---|---|
| Title | A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen |
| Official title | A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sickle Cell Disease, Thalassemia, Hemoglobinopathies |
| Intervention type | Other |
| Interventions | Busulfan, Fludarabine, cyclosporine A and MMF |
| Enrollment | 8 |
| Start date | Jun 1, 2002 |
| Primary completion | May 1, 2014 |
| Completion | May 1, 2014 |
| First posted | Jan 29, 2007 |
| Last update posted | Aug 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: